Strong volume growth and exceptional earnings

BioMar delivered volume growth of 5% year on year in Q3. In the same period, revenue increased by 19% year on year to DKK 5,807 million, while EBIT increased to DKK 618 million. Guidance raised on EBIT and revenue.

The exceptional earnings in the quarter were driven mainly by the Salmon segment and Selected Species, reflecting higher volumes and market share in some markets, temporary raw material market conditions, positive exchange rate movements as well as BioMar’s sourcing flexibility and formulation expertise. ROIC including goodwill increased to 27.1%.

BioMar raises the 2026 guidance for revenue and EBIT and lowers its volume guidance. The update reflects an updated outlook for the remainder of the year based on recent market developments and the impact of weather events, including higher raw material prices, customer demand and current exchange rates, as well as strong earnings performance in the first nine months of 2026.

^{Forward-looking statements}

^{This press release contains forward-looking statements, which are based on current expectations, projections and assumptions about future events. Forward-looking statements are statements (other than statements of historical fact) relating to future events and BioMar’s anticipated or planned financial and operational performance. The words “may”, “will”, “should”, “expect”, “anticipate”, “believe”, “estimate”, “plan”, “predict”, “intend” or variations of these words, including negatives thereof, as well as other statements regarding matters that are not historical facts or regarding future events or prospects, constitute forward-looking statements. BioMar has based these forward-looking statements on its current views with respect to future events and financial performance. These views involve a number of known or unknown risks, uncertainties and assumptions, which could cause actual results to differ materially from those predicted in the forward-looking statements and from the past performance of BioMar. Although BioMar believes that the estimates and projections reflected in the forward-looking statements are reasonable, they may prove materially incorrect, and actual results may materially differ, e.g., as the result of risks related to the industry in general or BioMar in particular, including those described in BioMar’s Annual Report 2025 and other information made available by BioMar. As a result, you should not and may not rely on these forward looking statements as a prediction of actual results. Forward-looking statements speak as of the date of this press release and no one undertakes to publicly update or revise any such forward-looking statements, whether as a result of new information, future events or otherwise, except to the extent required by law.}